Group: Neuropharmacology of addictions and degenerative disorders
Acronym: NEUROFAN
Registry number: G20/5-08
School/Centre: PHARMACY
Memberships:
Research thematic areas:
UNESCO Code: 3209
Keywords:
Addictions, Neurodegeneration, Neuroinflammation
Relevant characteristics of the research group (description of the group's activity): The Neuropharmacology of addictions and degenerative disorders Group (NEUROFAN) carries out all the identification phases of new biomarkers and therapeutic targets in illnesses of the central nervous system such as the addictive disorders or neurodegenerative diseases. It also carries out preclinical validation of new compounds with therapeutic potential. In order to do that, the group's lines of research encompass the study of molecular mechanisms involved in drug dependencies and neurodegenerative diseases or those that invlove neurodegeneration such as alcoholism. A common mechanism in this type of pathologies is neuroinflammation, which, when chronic, aggravates neurodegenerative processes. It is therefore of great interest to study the mechanisms that trigger and perpetuate neuroinflammation. This has led the group to discover new targets in neuroinflammation and to study their pharmacological modulation as a new therapeutic strategy in multiple diseases that involve neuroinflammatory processes. Web page: https://neurofan.ceu.es/ Video: Contact: [email protected]
The Neuropharmacology of addictions and degenerative disorders Group (NEUROFAN) carries out all the identification phases of new biomarkers and therapeutic targets in illnesses of the central nervous system such as the addictive disorders or neurodegenerative diseases. It also carries out preclinical validation of new compounds with therapeutic potential.
In order to do that, the group's lines of research encompass the study of molecular mechanisms involved in drug dependencies and neurodegenerative diseases or those that invlove neurodegeneration such as alcoholism. A common mechanism in this type of pathologies is neuroinflammation, which, when chronic, aggravates neurodegenerative processes. It is therefore of great interest to study the mechanisms that trigger and perpetuate neuroinflammation. This has led the group to discover new targets in neuroinflammation and to study their pharmacological modulation as a new therapeutic strategy in multiple diseases that involve neuroinflammatory processes.
Web page:
Video:
Contact: [email protected]